Trupanion, Inc. (NASDAQ:TRUP) Receives Consensus Rating of “Moderate Buy” from Analysts

Shares of Trupanion, Inc. (NASDAQ:TRUP) have been given a consensus rating of “Moderate Buy” by the seven analysts that are currently covering the firm, MarketBeat.com reports. Two analysts have rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company. The average 1-year target price among brokerages that have issued ratings on the stock in the last year is $45.33.

TRUP has been the topic of a number of recent analyst reports. Northland Securities upped their target price on Trupanion from $45.00 to $50.00 and gave the company a “market perform” rating in a research report on Thursday, October 31st. Stifel Nicolaus upped their price target on shares of Trupanion from $42.00 to $44.00 and gave the company a “hold” rating in a report on Monday, January 6th. Finally, Piper Sandler raised shares of Trupanion from a “neutral” rating to an “overweight” rating and set a $57.00 price objective for the company in a report on Thursday, January 23rd.

Trupanion Stock Down 2.2 %

Shares of NASDAQ:TRUP opened at $46.01 on Friday. The company has a 50 day moving average of $49.71 and a two-hundred day moving average of $47.10. Trupanion has a 52-week low of $19.69 and a 52-week high of $57.90. The company has a quick ratio of 1.66, a current ratio of 1.66 and a debt-to-equity ratio of 0.40. The company has a market capitalization of $1.95 billion, a price-to-earnings ratio of -143.78, a price-to-earnings-growth ratio of 8.27 and a beta of 1.60.

Insider Activity

In related news, SVP Emily Dreyer sold 3,100 shares of Trupanion stock in a transaction on Friday, November 22nd. The stock was sold at an average price of $54.85, for a total transaction of $170,035.00. Following the completion of the sale, the senior vice president now owns 24,708 shares of the company’s stock, valued at approximately $1,355,233.80. This trade represents a 11.15 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Steve Weinrauch sold 11,916 shares of Trupanion stock in a transaction dated Thursday, November 21st. The shares were sold at an average price of $53.00, for a total value of $631,548.00. Following the sale, the executive vice president now owns 48,978 shares of the company’s stock, valued at approximately $2,595,834. This represents a 19.57 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 26,597 shares of company stock valued at $1,416,742 over the last three months. Insiders own 5.50% of the company’s stock.

Institutional Trading of Trupanion

Large investors have recently made changes to their positions in the stock. SBI Securities Co. Ltd. acquired a new stake in shares of Trupanion in the fourth quarter worth $25,000. Jones Financial Companies Lllp raised its holdings in Trupanion by 71.7% in the 4th quarter. Jones Financial Companies Lllp now owns 570 shares of the financial services provider’s stock worth $27,000 after acquiring an additional 238 shares during the period. Quest Partners LLC bought a new position in Trupanion in the 3rd quarter worth $37,000. Wilmington Savings Fund Society FSB bought a new stake in Trupanion during the third quarter valued at about $54,000. Finally, GAMMA Investing LLC boosted its holdings in Trupanion by 70.4% during the third quarter. GAMMA Investing LLC now owns 1,442 shares of the financial services provider’s stock valued at $61,000 after acquiring an additional 596 shares during the period.

About Trupanion

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.